so in addition to 20 years' worth of patent protection, this athey now have, they want 12 years of market exclusivity which has the exact same effect as patent protection. they get 20 year, then another 12. then when f.d.a. grants a drug market exclusivity, it means that f.d.a. will not approve any generic version of that drug, period. after the first 12 years of market exclusivity is over, the biologics industry want to be able to slightly modify their products, just a slight modification, and they get another 12 years of market exclusivity. and if they slightly modify their product again, they want another 12 years and another 12 years. in other words, madam president, they want no generic competition. we have generic competition in all kinds of drugs that are very, very well-known, for pharmaceuticals. but there is no provision for any kind of generic competition for these biologics. the federal trade commission, a government report with no skin in the came, with no belief that one product is better than than another, with no ties to the drug industry, the f.t.c. issue add report asser

i think a lot -- the proof will be in the pudding, athey say, how congress and the administration begins to implement health care reform or climate change policy. those details about how to spend and revenues will be matched will be the critical issue. >> regardless of how we spend, let's assume for the moment, we spend on all the best things in the world, the deficit numbers don't change, right? the debt numbers don't change. we're still going to spend that $634 billion on health care or something else, we're still going to spend the money on something. so the bottom line numbers don't change. >> well, my understanding was that $634 billion place holder came with some perspective revenue offsets from the carbon permits and from upper class tax increases. mr. ryan says no, but -- >> i'll yield. >> half from medicare cuts and half from the upper tax -- >> okay. so at least, there was a match there, as i said this is all about execution and that's the key issue. >> okay. when the cbo was here, i guess about a week or two weeks ago, one of the questions, i referenced to you being a historia